Literature DB >> 25880017

Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism.

Andrea Grillo1, Stella Bernardi1, Andrea Rebellato2, Bruno Fabris1, Moreno Bardelli1, Jacopo Burrello3, Franco Rabbia3, Franco Veglio3, Francesco Fallo2, Renzo Carretta1.   

Abstract

The aim of this study was to investigate the short-term blood pressure (BP) variability (BPV) derived from ambulatory blood pressure monitoring (ABPM) in patients with primary aldosteronism (PA), either idiopathic hyperaldosteronism (IHA) or aldosterone-producing adenoma (APA), in comparison with patients with essential hypertension (EH) and normotensive (NT) controls. Thirty patients with PA (16 with IHA and 14 with APA), 30 patients with EH, and 30 NT controls, matched for sex, age, body mass index, and antihypertensive therapy, were studied. The standard deviation (SD) of 24-hour, daytime, and nighttime BP; 24-hour weighted SD of BP; and 24-hour BP average real variability were not different between patients with PA and those with EH (P=not significant). All BPV indices were higher in patients with PA, either IHA or APA subtypes, and patients with EH, compared with NT controls (P<.001 to P<.05). ABPM-derived short-term BPV is increased in patients with PA, and it may represent an additional cardiovascular risk factor in this disease. The role of aldosterone excess in BPV has to be clarified.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25880017      PMCID: PMC8031694          DOI: 10.1111/jch.12551

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  43 in total

1.  Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study.

Authors:  M Kikuya; A Hozawa; T Ohokubo; I Tsuji; M Michimata; M Matsubara; M Ota; K Nagai; T Araki; H Satoh; S Ito; S Hisamichi; Y Imai
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

2.  Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.

Authors:  Guilhem du Cailar; Pierre Fesler; Jean Ribstein; Albert Mimran
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

3.  Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.

Authors:  E Miyajima; Y Yamada; Y Yoshida; T Matsukawa; H Shionoiri; O Tochikubo; M Ishii
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

4.  Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.

Authors:  Paolo Mulatero; Chiara Bertello; Norlela Sukor; Richard Gordon; Denis Rossato; Nicholas Daunt; David Leggett; Giulio Mengozzi; Franco Veglio; Michael Stowasser
Journal:  Hypertension       Date:  2010-02-01       Impact factor: 10.190

5.  Hemodynamic characteristics of primary aldosteronism.

Authors:  R C Tarazi; M M Ibrahim; E L Bravo; H P Dustan
Journal:  N Engl J Med       Date:  1973-12-20       Impact factor: 91.245

6.  Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.

Authors:  Natacha Levi-Marpillat; Isabelle Macquin-Mavier; Anne-Isabelle Tropeano; Gianfranco Parati; Patrick Maison
Journal:  Hypertens Res       Date:  2014-03-27       Impact factor: 3.872

7.  Prognostic value of different indices of blood pressure variability in hypertensive patients.

Authors:  Sante D Pierdomenico; Marta Di Nicola; Anna L Esposito; Rocco Di Mascio; Enzo Ballone; Domenico Lapenna; Franco Cuccurullo
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

8.  Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism.

Authors:  F Veglio; R Melchio; F Rabbia; P Molino; G Martini; L Chiandussi
Journal:  Am J Hypertens       Date:  1995-05       Impact factor: 2.689

9.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

10.  Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.

Authors:  P Mulatero; F Veglio; C Pilon; F Rabbia; C Zocchi; P Limone; M Boscaro; N Sonino; F Fallo
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

View more
  4 in total

1.  Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.

Authors:  H Wang; C Weng; H Chen
Journal:  J Hum Hypertens       Date:  2017-01-19       Impact factor: 3.012

2.  Aldosterone: Yet Another Path to Blood Pressure Variability and Target Organ Damage.

Authors:  Brian S Decker; Howard J Pratt
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-16       Impact factor: 3.738

3.  Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism.

Authors:  Andrea Grillo; Stella Bernardi; Andrea Rebellato; Bruno Fabris; Moreno Bardelli; Jacopo Burrello; Franco Rabbia; Franco Veglio; Francesco Fallo; Renzo Carretta
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-16       Impact factor: 3.738

4.  Hypertension and End-Organ Damage in Children--Is the Picture Less Fuzzy Now?

Authors:  Tibor Fülöp; Mehul P Dixit
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.